Literature DB >> 26441078

Cancer rehabilitation and palliative care--two important parts of comprehensive cancer care.

Richard Crevenna1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26441078     DOI： 10.1007/s00520-015-2977-1

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  5 in total

1.  Response to editorial by Richard Crevenna, MD, regarding "cancer rehabilitation and palliative care: critical components in the delivery of high-quality oncology services" by Silver et al.

Authors:  Julie K Silver; Sean R Smith; Eric M Wisotzky; Vishwa S Raj; Jack B Fu; Rebecca A Kirch
Journal:  Support Care Cancer       Date:  2015-08-23       Impact factor: 3.603

Review 2.  Impairment-driven cancer rehabilitation: an essential component of quality care and survivorship.

Authors:  Julie K Silver; Jennifer Baima; R Samuel Mayer
Journal:  CA Cancer J Clin       Date:  2013-07-15       Impact factor: 508.702

3.  The prevalence of potentially modifiable functional deficits and the subsequent use of occupational and physical therapy by older adults with cancer.

Authors:  Mackenzi Pergolotti; Allison M Deal; Jessica Lavery; Bryce B Reeve; Hyman B Muss
Journal:  J Geriatr Oncol       Date:  2015-01-19       Impact factor: 3.599

Review 4.  Conceptual models for integrating palliative care at cancer centers.

Authors:  Eduardo Bruera; David Hui
Journal:  J Palliat Med       Date:  2012-08-27       Impact factor: 2.947

5.  Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer.

Authors:  Andrea L Cheville; Andrea B Troxel; Jeffrey R Basford; Alice B Kornblith
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544
  5 in total
  9 in total

1.  Physical medicine and rehabilitation--a relevant interdisciplinary speciality.

Authors:  Richard Crevenna
Journal:  Wien Med Wochenschr       Date:  2016-02

Review 2.  Cancer rehabilitation in Austria--aspects of Physical Medicine and Rehabilitation.

Authors:  Bruno Maehr; Mohammad Keilani; Christoph Wiltschke; Marco Hassler; Thomas Licht; Christine Marosi; Elisabeth Huetterer; Fadime Cenik; Richard Crevenna
Journal:  Wien Med Wochenschr       Date:  2016-01-12

3.  Evaluation of cancer rehabilitation in Austria.

Authors:  Richard Crevenna
Journal:  Wien Med Wochenschr       Date:  2018-10

4.  Return-to-work outcomes in cancer survivors.

Authors:  Richard Crevenna
Journal:  Support Care Cancer       Date:  2017-07-18       Impact factor: 3.603

5.  Role of physical medicine for cancer rehabilitation and return to work under the premise of the "Wiedereingliederungsteilzeitgesetz".

Authors:  Fadime Cenik; Bruno Mähr; Stefano Palma; Mohammad Keilani; Thomas Nowotny; Richard Crevenna
Journal:  Wien Klin Wochenschr       Date:  2019-05-13       Impact factor: 1.704

Review 6.  Typical aspects in the rehabilitation of cancer patients suffering from metastatic bone disease or multiple myeloma.

Authors:  Mohammad Keilani; Franz Kainberger; Anna Pataraia; Timothy Hasenöhrl; Barbara Wagner; Stefano Palma; Fadime Cenik; Richard Crevenna
Journal:  Wien Klin Wochenschr       Date:  2019-07-02       Impact factor: 1.704

Review 7.  Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity.

Authors:  Dong-Woo Kang; Rebekah L Wilson; Cami N Christopher; Amber J Normann; Oscar Barnes; Jordan D Lesansee; Gyuhwan Choi; Christina M Dieli-Conwright
Journal:  Front Cardiovasc Med       Date:  2022-01-14

8.  Commentary: Onco-Esthetics Dilemma: Is There a Role for Electrocosmetic-Medical Devices?

Authors:  Andrej Zdravkovic; Lovro Markovic; Richard Crevenna
Journal:  Front Oncol       Date:  2021-09-30       Impact factor: 6.244

9.  Relevant parameters for recommendations of physical activity in patients suffering from multiple myeloma : A pilot study.

Authors:  Fadime Cenik; Mohammad Keilani; Timothy Hasenöhrl; Dominikus Huber; Bianca Stuhlpfarrer; Anna Pataraia; Richard Crevenna
Journal:  Wien Klin Wochenschr       Date:  2019-11-29       Impact factor: 1.704
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.